Skip to main content
. 2015 Aug 28;21(32):9598–9606. doi: 10.3748/wjg.v21.i32.9598

Figure 3.

Figure 3

Distribution of Ishak fibrosis scores for the entecavir and lamivudine arms at baseline and post-treatment. The green areas represent the percentage of patients who had an Ishak fibrosis score of 0 post-treatment. ETV: Entecavir; LAM: Lamivudine; ADV: Adefovir.